REFERENCES
- CSAT Buprenorphine Information Center. Buprenorphine. US Department of Health and Human Services, Available at http://www.buprenorphine.samhsa.gov/(accessed September 19, 2008)
- Kraft W K, Gibson E, Dysart K, et al. Sublingual buprenorphine for treatment of neonatal abstinence syndrome: a randomized trial. Pediatrics 2008; 122: e601–e607
- Geib A, Babu K, Ewald M B, Boyer E W. Adverse effects in children after unintentional buprenorphine exposure. Pediatrics 2006; 118: 1746–1751
- Hayes B D, Klein-Schwartz W, Doyon S. Toxicity of buprenorphine overdoses in children. Pediatrics 2008; 121: e782–e786
- Schwarz K A, Cantrell F L, Vohra R B, Clark R F. Suboxone (buprenorphine/ naloxone) toxicity in pediatric patients: a case report. Pediatr Emer Care 2007; 23: 651–652
- Subutex and Suboxone Approved to Treat Opiate Dependence. 2002, Available at http://www.fda.gov/bbs/topics/answers FDA Talk Paper (accessed September 19, 2008)
- Van Dorp E, Yassen A, Sarton E, et al. Naloxone reversal of buprenorphine induced respiratory depression. Anesthesiology 2006; 105: 51–57
- McKeown N J, West P L, Hendrickson R G. Persistent toxicity after suboxone ingestion in a toddler. Clin Toxicol 2008; 48: 619